How to Start a Peptide Therapy Practice: A Provider's Complete Roadmap

Why Peptide Therapy Is a Compelling Practice Addition

Peptide therapy represents one of the fastest-growing segments in functional and integrative medicine. The global peptide therapeutics market is projected to exceed $50 billion by 2030. More importantly, it addresses a massive unmet need: millions of patients with fatigue, body composition issues, suboptimal hormones, and recovery challenges who have been dismissed by conventional medicine. Providers who build peptide competency now are positioning themselves at the leading edge of a clinical shift that is already underway.

Legal and Regulatory Framework

Understanding the regulatory landscape is the essential first step. Peptide therapy exists at the intersection of compounding pharmacy law, DEA scheduling, and scope of practice regulations.

• ✓Prescribing authority: NPs, PAs, MDs, and DOs can prescribe most compounded peptides in most states — verify your state scope of practice for compounded medications
• ✓FDA status: Many peptides (including BPC-157, CJC-1295, and Ipamorelin) are currently available as compounded medications under the 503A/503B compounding framework
• ✓DEA scheduling: Most GH secretagogues and healing peptides are not scheduled. Exceptions include certain peptides with stimulant properties — verify before prescribing
• ✓Telehealth rules: Post-pandemic, most states allow telehealth prescribing for peptides with appropriate informed consent and follow-up protocols
• ✓Document thoroughly: Maintain clear records of indication, informed consent, prescription rationale, and follow-up monitoring

Selecting Compounding Pharmacy Partners

Quality compounding is the single most important factor in patient outcomes and safety. Not all compounding pharmacies are equal.

• ✓PCAB accreditation: Look for Pharmacy Compounding Accreditation Board accreditation as a minimum quality signal
• ✓COA (Certificate of Analysis): Reputable pharmacies provide third-party testing certificates for purity, potency, and sterility on every batch
• ✓503A vs 503B: 503A pharmacies compound for individual prescriptions; 503B outsourcing facilities can compound in larger batches. Both can be appropriate for your practice model.
• ✓Vetting questions to ask: Who does your third-party testing? What is your endotoxin testing protocol? Can I review your SOPs for sterile compounding?
• ✓Avoid: Foreign-sourced peptides, unverified online suppliers, and any pharmacy unwilling to share COAs

Building Your Clinical Protocol Library

Successful peptide practices run on well-defined, reproducible protocols. Start with 3-5 core protocols rather than trying to offer everything at once.

• ✓GH optimization stack (CJC-1295 + Ipamorelin): Your highest-volume peptide protocol — anti-aging, body recomposition, sleep, recovery
• ✓GI healing protocol (BPC-157 ± Glutamine): IBD, SIBO recovery, post-antibiotic gut restoration, leaky gut
• ✓Weight management (Semaglutide or Tirzepatide + lifestyle): GLP-1 therapy with metabolic monitoring
• ✓Sexual health (PT-141 ± hormone optimization): Men and women with low libido
• ✓Tissue repair (TB-500 + BPC-157): Joint injuries, post-surgical recovery, chronic tendinopathy
• ✓Each protocol needs: Inclusion/exclusion criteria, baseline labs, consent form, dosing titration schedule, monitoring plan, and follow-up cadence

Lab Monitoring and Patient Safety Systems

Peptide therapy is low-risk when properly monitored — but the monitoring is non-negotiable. Build the lab infrastructure before you see your first patient.

• ✓Baseline labs by protocol: GH protocols → IGF-1, fasting glucose, insulin; GLP-1 → HbA1c, lipids, GFR; Hormone-adjacent protocols → full hormone panel
• ✓Follow-up cadence: At minimum, recheck relevant labs at 8-12 weeks into any new protocol
• ✓IGF-1 targets: Most adults do well in the 150-300 ng/mL range. Watch for values above 350 and adjust dose.
• ✓Patient consent: Document that risks, alternatives, and monitoring requirements have been discussed. Include off-label status where applicable.
• ✓Adverse event protocol: Have a clear process for patients to report unexpected symptoms and for you to respond quickly

Practice Models and Pricing

Peptide therapy practices typically run on a cash-pay or hybrid model, since most insurance does not cover compounded peptides.

• ✓Consultation fee: $150-400 for initial 45-60 min new patient consult with full history and protocol design
• ✓Monthly membership: $149-299/month covering monthly check-ins, lab review, and protocol adjustments
• ✓Medication cost: Patients typically pay compounding pharmacy directly ($80-300/month depending on protocol)
• ✓Lab fees: Either passed through from lab or bundled into membership for higher-tier members
• ✓Telehealth model: Dramatically reduces overhead — many successful peptide practices are 100% virtual
• ✓Hybrid model: Initial in-person or virtual consultation, then asynchronous monitoring with quarterly video check-ins

Patient Acquisition for Peptide Practices

The peptide therapy patient is increasingly sophisticated — they have already researched their options and are looking for a provider who matches their level of knowledge.

• ✓SEO and content marketing: Blog posts, YouTube videos, and podcast appearances on peptide topics generate warm inbound leads at low cost
• ✓Provider directories: List on functional medicine and peptide-specific directories. BioRoot AI features a provider directory where you can connect with patients actively seeking peptide-literate providers.
• ✓Social media: Instagram and YouTube perform well for before/after content and educational carousels on GLP-1, GH peptides, and hormone optimization
• ✓Referral partnerships: Build relationships with gyms, sports medicine practices, aesthetics clinics, and weight loss centers — all natural referral partners
• ✓Facebook groups: Peptide and functional medicine patient groups on Facebook are highly active — educational content (not advertising) builds authority

Using Technology to Scale Your Practice

The most successful peptide practices run lean by leveraging technology for patient intake, monitoring, and education. AI-assisted intake tools that collect detailed symptom data before the first appointment allow providers to spend more consultation time on clinical decision-making rather than history-taking. BioRoot AI was built specifically for this use case — patients complete a comprehensive health assessment that generates structured data providers can review before the visit, dramatically improving the efficiency and quality of the first consultation.